Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

The NAIMS cooperative pilot project: Design, implementation and future directions.

Oh J, Bakshi R, Calabresi PA, Crainiceanu C, Henry RG, Nair G, Papinutto N, Constable RT, Reich DS, Pelletier D, Rooney W, Schwartz D, Tagge I, Shinohara RT, Simon JH, Sicotte NL; NAIMS Cooperative Steering Committee.

Mult Scler. 2018 Nov;24(13):1770-1772. doi: 10.1177/1352458517739990. Epub 2017 Nov 6.

PMID:
29106329
2.

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.

Traboulsee A, Simon JH, Stone L, Fisher E, Jones DE, Malhotra A, Newsome SD, Oh J, Reich DS, Richert N, Rammohan K, Khan O, Radue EW, Ford C, Halper J, Li D.

AJNR Am J Neuroradiol. 2016 Mar;37(3):394-401. doi: 10.3174/ajnr.A4539. Epub 2015 Nov 12.

3.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

4.

Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.

Kinkel RP, Simon JH, O'Connor P, Hyde R, Pace A.

Mult Scler Relat Disord. 2014 Nov;3(6):712-9. doi: 10.1016/j.msard.2014.08.003. Epub 2014 Aug 27.

PMID:
25891550
5.

Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial.

Simon JH, Kinkel RP, Kollman C, O'Connor P, Fisher E, You X, Hyde R; CHAMPIONS Investigators Group.

Mult Scler. 2015 Apr;21(4):415-22. doi: 10.1177/1352458514547407. Epub 2014 Oct 24.

PMID:
25344370
6.

Simple MRI metrics contribute to optimal care of the patient with multiple sclerosis.

Simon JH, Bermel RA, Rudick RA.

AJNR Am J Neuroradiol. 2014 May;35(5):831-2. doi: 10.3174/ajnr.A3937. Epub 2014 Apr 3. No abstract available.

7.

MRI outcomes in the diagnosis and disease course of multiple sclerosis.

Simon JH.

Handb Clin Neurol. 2014;122:405-25. doi: 10.1016/B978-0-444-52001-2.00017-0. Review.

PMID:
24507528
8.

Response to comment on letter for: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'.

Hamilton B, Liu S, Simon JH, Bourdette D.

Mult Scler. 2014 Jun;20(7):899. doi: 10.1177/1352458513515960. Epub 2013 Dec 18. No abstract available.

PMID:
24351436
9.

Evaluation of the reliability and accuracy of using cone-beam computed tomography for diagnosing periapical cysts from granulomas.

Guo J, Simon JH, Sedghizadeh P, Soliman ON, Chapman T, Enciso R.

J Endod. 2013 Dec;39(12):1485-90. doi: 10.1016/j.joen.2013.08.019. Epub 2013 Sep 27.

PMID:
24238434
10.

The relationship of endodontic-periodontic lesions.

Simon JH, Glick DH, Frank AL.

J Endod. 2013 May;39(5):e41-6. doi: 10.1016/j.joen.2013.02.006. No abstract available.

PMID:
23611400
11.

Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.

Bermel RA, You X, Foulds P, Hyde R, Simon JH, Fisher E, Rudick RA.

Ann Neurol. 2013 Jan;73(1):95-103. doi: 10.1002/ana.23758.

PMID:
23378325
12.

Bacterial flora of dental periradicular lesions analyzed by the 454-pyrosequencing technology.

Saber MH, Schwarzberg K, Alonaizan FA, Kelley ST, Sedghizadeh PP, Furlan M, Levy TA, Simon JH, Slots J.

J Endod. 2012 Nov;38(11):1484-8. doi: 10.1016/j.joen.2012.06.037. Epub 2012 Aug 9.

PMID:
23063222
13.

Modification of the ferret model for pneumonia from seasonal human influenza A virus infection.

van den Brand JM, Stittelaar KJ, Leijten LM, van Amerongen G, Simon JH, Osterhaus AD, Kuiken T.

Vet Pathol. 2012 May;49(3):562-8. doi: 10.1177/0300985811429812. Epub 2012 Jan 18.

PMID:
22262355
14.

Genogroup I and II picobirnaviruses in respiratory tracts of pigs.

Smits SL, Poon LL, van Leeuwen M, Lau PN, Perera HK, Peiris JS, Simon JH, Osterhaus AD.

Emerg Infect Dis. 2011 Dec;17(12):2328-30. doi: 10.3201/eid1712.110934.

15.

Metagenomic analysis of the viral flora of pine marten and European badger feces.

van den Brand JM, van Leeuwen M, Schapendonk CM, Simon JH, Haagmans BL, Osterhaus AD, Smits SL.

J Virol. 2012 Feb;86(4):2360-5. doi: 10.1128/JVI.06373-11. Epub 2011 Dec 14.

16.

Significance of human cytomegalovirus and Epstein-Barr virus in inducing cytokine expression in periapical lesions.

Sabeti M, Kermani V, Sabeti S, Simon JH.

J Endod. 2012 Jan;38(1):47-50. doi: 10.1016/j.joen.2011.09.026. Epub 2011 Nov 21.

PMID:
22152619
17.

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O'Connor P, Montalban X, Miller DH, Filippi M.

Nat Rev Neurol. 2011 Dec 6;8(1):13-21. doi: 10.1038/nrneurol.2011.190. Review.

PMID:
22143362
18.

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance.

Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH; Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance Investigators.

Arch Neurol. 2012 Feb;69(2):183-90. doi: 10.1001/archneurol.2011.1426. Epub 2011 Oct 10.

PMID:
21987393
19.

Efficacy of the enamel matrix derivative to induce cementogenesis in vital and endodontically treated teeth with osseous dehiscence defects.

Al-Hezaimi K, Naghshbandi J, Al-Rasheed A, Merdad K, Simon JH, Rotstein I.

Dent Traumatol. 2011 Oct;27(5):350-5. doi: 10.1111/j.1600-9657.2011.01019.x. Epub 2011 Jul 3.

PMID:
21722307
20.

Pulmonary pathology of pandemic influenza A/H1N1 virus (2009)-infected ferrets upon longitudinal evaluation by computed tomography.

Veldhuis Kroeze EJ, van Amerongen G, Dijkshoorn ML, Simon JH, de Waal L, Hartmann IJ, Krestin GP, Kuiken T, Osterhaus AD, Stittelaar KJ.

J Gen Virol. 2011 Aug;92(Pt 8):1854-8. doi: 10.1099/vir.0.032805-0. Epub 2011 May 4.

21.

Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.

Baras B, de Waal L, Stittelaar KJ, Jacob V, Giannini S, Kroeze EJ, van den Brand JM, van Amerongen G, Simon JH, Hanon E, Mossman SP, Osterhaus AD.

Vaccine. 2011 Mar 3;29(11):2120-6. doi: 10.1016/j.vaccine.2010.12.125. Epub 2011 Jan 14.

PMID:
21238573
22.

Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets.

Baras B, Stittelaar KJ, Kuiken T, Jacob V, Bernhard R, Giannini S, de Waal L, van Amerongen G, Simon JH, Osterhaus AD, Hanon E, Mossman SP.

Vaccine. 2011 Mar 3;29(11):2092-9. doi: 10.1016/j.vaccine.2010.12.128. Epub 2011 Jan 13.

PMID:
21237275
23.

Identification and characterization of deer astroviruses.

Smits SL, van Leeuwen M, Kuiken T, Hammer AS, Simon JH, Osterhaus AD.

J Gen Virol. 2010 Nov;91(Pt 11):2719-22. doi: 10.1099/vir.0.024067-0. Epub 2010 Jul 28.

PMID:
20668117
24.

Human astrovirus infection in a patient with new-onset celiac disease.

Smits SL, van Leeuwen M, van der Eijk AA, Fraaij PL, Escher JC, Simon JH, Osterhaus AD.

J Clin Microbiol. 2010 Sep;48(9):3416-8. doi: 10.1128/JCM.01164-10. Epub 2010 Jun 23.

25.

Human picobirnaviruses identified by molecular screening of diarrhea samples.

van Leeuwen M, Williams MM, Koraka P, Simon JH, Smits SL, Osterhaus AD.

J Clin Microbiol. 2010 May;48(5):1787-94. doi: 10.1128/JCM.02452-09. Epub 2010 Mar 24.

26.

Cytomegalovirus-infected inflammatory cells in dental periapical lesions.

Sabeti M, Daneshmand A, Simon JH, Slots J.

Oral Microbiol Immunol. 2009 Oct;24(5):434-6. doi: 10.1111/j.1399-302X.2009.00540.x.

PMID:
19702961
27.

MTA preparations from different origins may vary in their antimicrobial activity.

Al-Hezaimi K, Al-Shalan TA, Naghshbandi J, Simon JH, Rotstein I.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 May;107(5):e85-8. doi: 10.1016/j.tripleo.2009.01.045.

PMID:
19426914
28.

Successful treatment of a radicular groove by intentional replantation and Emdogain therapy: four years follow-up.

Al-Hezaimi K, Naghshbandi J, Simon JH, Rotstein I.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Mar;107(3):e82-5. doi: 10.1016/j.tripleo.2008.11.012. Epub 2009 Jan 25.

PMID:
19168375
29.

Variants of multiple sclerosis.

Simon JH, Kleinschmidt-DeMasters BK.

Neuroimaging Clin N Am. 2008 Nov;18(4):703-16, xi. doi: 10.1016/j.nic.2008.06.003. Review.

PMID:
19068410
30.

Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma.

Simon JH, Paulino AC, Ritchie JM, Mayr NA, Buatti JM.

Sarcoma. 2003;7(1):1-7. doi: 10.1080/1357714031000114147.

31.

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.

Baras B, Stittelaar KJ, Simon JH, Thoolen RJ, Mossman SP, Pistoor FH, van Amerongen G, Wettendorff MA, Hanon E, Osterhaus AD.

PLoS One. 2008 Jan 2;3(1):e1401. doi: 10.1371/journal.pone.0001401.

32.

Fast multislice mapping of the myelin water fraction using multicompartment analysis of T2* decay at 3T: a preliminary postmortem study.

Du YP, Chu R, Hwang D, Brown MS, Kleinschmidt-DeMasters BK, Singel D, Simon JH.

Magn Reson Med. 2007 Nov;58(5):865-70.

33.

Clinical indications for digital imaging in dento-alveolar trauma. Part 2: root resorption.

Cohenca N, Simon JH, Mathur A, Malfaz JM.

Dent Traumatol. 2007 Apr;23(2):105-13.

PMID:
17367458
34.

Clinical indications for digital imaging in dento-alveolar trauma. Part 1: traumatic injuries.

Cohenca N, Simon JH, Roges R, Morag Y, Malfaz JM.

Dent Traumatol. 2007 Apr;23(2):95-104. Review.

35.

Brain atrophy in multiple sclerosis: what we know and would like to know.

Simon JH.

Mult Scler. 2006 Dec;12(6):679-87. Review.

PMID:
17262994
36.

Antibacterial effect of two mineral trioxide aggregate (MTA) preparations against Enterococcus faecalis and Streptococcus sanguis in vitro.

Al-Hezaimi K, Al-Shalan TA, Naghshbandi J, Oglesby S, Simon JH, Rotstein I.

J Endod. 2006 Nov;32(11):1053-6. Epub 2006 Jul 26.

PMID:
17055905
37.

Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.

Simon JH, Zhang S, Laidlaw DH, Miller DE, Brown M, Corboy J, Bennett J.

J Magn Reson Imaging. 2006 Nov;24(5):983-8.

PMID:
17024655
38.

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, Miller DH, Montalban X, Simon JH, Polman C, Filippi M.

Lancet Neurol. 2006 Oct;5(10):841-52. Review.

PMID:
16987731
39.

Differential diagnosis of large periapical lesions using cone-beam computed tomography measurements and biopsy.

Simon JH, Enciso R, Malfaz JM, Roges R, Bailey-Perry M, Patel A.

J Endod. 2006 Sep;32(9):833-7. Epub 2006 Jul 7.

PMID:
16934625
40.

Update on multiple sclerosis.

Simon JH.

Magn Reson Imaging Clin N Am. 2006 May;14(2):203-24, vi.

PMID:
16873011
41.

Healing of apical periodontitis after endodontic treatment with and without obturation in dogs.

Sabeti MA, Nekofar M, Motahhary P, Ghandi M, Simon JH.

J Endod. 2006 Jul;32(7):628-33. Epub 2006 May 2.

PMID:
16793468
42.

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

Li DK, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, Frank JA, Kappos L, Miller DH, Simon JH, Wolinsky JS, Filippi M; Sylvia Lawry Centre for MS Research.

Neurology. 2006 May 9;66(9):1384-9.

PMID:
16682671
43.
44.

Anatomical redesign for the treatment of dens invaginatus type III with open apexes: a literature review and case presentation.

Silberman A, Cohenca N, Simon JH.

J Am Dent Assoc. 2006 Feb;137(2):180-5. Review.

PMID:
16521383
45.

Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, Barkhof F, Frank JA, Grossman R, Paty DW, Radue EW, Wolinsky JS.

AJNR Am J Neuroradiol. 2006 Feb;27(2):455-61. No abstract available.

46.

Update on multiple sclerosis.

Simon JH.

Radiol Clin North Am. 2006 Jan;44(1):79-100, viii. Review.

PMID:
16297683
47.

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.

Barkhof F, Held U, Simon JH, Daumer M, Fazekas F, Filippi M, Frank JA, Kappos L, Li D, Menzler S, Miller DH, Petkau J, Wolinsky J; Sylvia Lawry Centre for MS Research.

Neurology. 2005 Nov 8;65(9):1447-54.

PMID:
16275834
48.

Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling.

Simon JH, Claassen E, Correa CE, Osterhaus AD.

Bull World Health Organ. 2005 Sep;83(9):707-10. Epub 2005 Sep 30.

49.

Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data.

Kozora E, Arciniegas DB, Filley CM, Ellison MC, West SG, Brown MS, Simon JH.

Cogn Behav Neurol. 2005 Sep;18(3):159-62.

PMID:
16175019
50.

Effect of white-colored mineral trioxide aggregate in different concentrations on Candida albicans in vitro.

Al-Hezaimi K, Al-Hamdan K, Naghshbandi J, Oglesby S, Simon JH, Rotstein I.

J Endod. 2005 Sep;31(9):684-6.

PMID:
16123707

Supplemental Content

Loading ...
Support Center